Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
To evaluate the use of HyBryte, a topical photosensitizing agent, to treat patients with patch/plaque phase cutaneous T-cell lymphoma (mycosis fungoides).
Epistemonikos ID: 34f6682c453343fa87a62884c27b6dfbd6d7839f
First added on: Jul 01, 2024